Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis

Autor: Barsky, Emily E., Pereira, Luis M., Sullivan, Keri J., Wong, Alanna, McAdam, Alexander J., Sawicki, Gregory S., Priebe, Gregory P., Goobie, Susan M.

Publikováno v: In Journal of Cystic Fibrosis May 2018 17(3):e25-e31

Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome

Autor: Khwaja, Omar S., Ho, Eugenia, Barnes, Katherine V., O'Leary, Heather M., Pereira, Luis M., Finkelstein, Yaron, Nelson, Charles A., Vogel-Farley, Vanessa, DeGregorio, Geneva, Holm, Ingrid A., Khatwa, Umakanth, Kapur, Kush, Alexander, Mark E., Finnegan, Deirdre M., Cantwell, Nicole G., Walco, Alexandra C., Rappaport, Leonard, Gregas, Matt, Fichorova, Raina N., Shannon, Michael W., Sur, Mriganka, Kaufmann, Walter E.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 2014 Mar . 111(12), 4596-4601.

Externí odkaz: https://www.jstor.org/stable/23771112

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Newborn screening for presymptomatic diagnosis of complement and phagocyte deficiencies

Autor: Dezfouli, Mahya, Bergström, Sofia, Skattum, Lillemor, Abolhassani, Hassan, Neiman, Maja, Torabi-Rahvar, Monireh, Franco Jarava, Clara, Martin-Nalda, Andrea, Ferrer Balaguer, Juana M., Slade, Charlotte A, Roos, Anja, Fernández Pereira, Luis M, López-Trascasa, Margarita, González-Granado, Luis I, Allende-Martinez, Luis M, Mizuno, Yumi, Yoshida, Yusuke, Friman, Vanda, Lundgren, Åsa, Aghamohammadi, Asghar, Rezaei, Nima, Hernández-Gonzalez, Manuel, Döbeln, Ulrika von, Truedsson, Lennart, Hara, Toshiro, Nonoyama, Shigeaki, Schwenk, Jochen M, Nilsson, Peter, Hammarström, Lennart

Publikováno v: Biblos-e Archivo. Repositorio Institucional de la UAM
Universidad Camilo José Cela (UCJC)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Frontiers in Immunology
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid

The clinical outcomes of primary immunodeficiencies (PIDs) are greatly improved by accurate diagnosis early in life. However, it is not common to consider PIDs before the manifestation of severe clinical symptoms. Including PIDs in the nation-wide ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7d6dec0003cee26547878d7443771ae3
http://hdl.handle.net/10486/693039

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.